To The Moon

Apple Inc.(AAPL)$ CEO Tim Cook has sold company shares valued at over $33 million.What Happened: Shares were sold over two days, from Apr. 1 to Apr. 2, at prices ranging from $168.62 to $170.03. On th

Feb 2 (Reuters) - Tesla is recalling 2.2 million vehicles, or nearly all of its electric vehicles in the United States, due to incorrect font size on warning lights, which increases the risk of a cras

The annual China International Import Expo, co-hosted by China's Ministry of Commerce and the Shanghai government, is the world's first import-themed national expo. ...

Nio is entering into the ultra-competitive smartphone business, and that's not something NIO stock traders ought to celebrate in 2023.

Tesla has cut prices in China for the second time in less than a week. The electric-vehicle maker looks intent on pressuring its competition in the world's largest car market.Tesla has reduced the price of its Model S luxury sedan in China to 754,900 yuan from 808,900 yuan, according to its official Weibo account. It also cut the price of its Model X SUV to 836,900 yuan from 898,900 yuan.The move extends price cuts across Tesla's range in China after it implemented insurance subsidies and price reductions for its lower-end Model 3 and Model Y vehicles over the weekend.It's not just in China that Tesla is competing on price. On Tuesday, Tesla launched cheaper versions of the Model S and Model X for order on its website in the U.S., at price points $10,000 below the standard versions but with limited range.Tesla shares were down 1.6% in premarket trading on Wednesday, having closed down 2.8% on Tuesday. U.S.-listed shares of Chinese EV makers also traded lower. NIO fell 3.7%, XPeng

Ratings actions from Benzinga: https://www.benzinga.com/quote/NIO/analyst-ratings (END) Dow Jones Newswires July 31, 2023 07:36 ET (11:36 GMT)

Cheshiji has been ordered to post an apology to Nio for 30 consecutive days and to pay 300,000 yuan in damages in a first-instance ruling. ...

HONG KONG/BEIJING, Jan 6 (Reuters) - China is in talks with Pfizer Inc to secure a licence that will

Aug 26 (Reuters) - Moderna is suing Pfizer and its German partner BioNTech for patent infringement i